Association of lysine pathway metabolites with moyamoya disease
Zihan Yin(Zunyi Medical University), Jizong Zhao(Capital Medical University), Shuai Kang(Capital Medical University), Chenglong Liu(Beijing Tian Tan Hospital), Peicong Ge(Capital Medical University), Xingju Liu(Capital Medical University), Yahui Zhao(China Railway Corporation), Chaofan Zeng(Capital Medical University), Hutao Xie(Capital Medical University), Dong Zhang(Yangpu Hospital of Tongji University), Qian Zhang(Brigham and Women's Hospital), Yan Zhang(Shenzhen Children's Hospital), Anjie Wang(Taiyuan Central Hospital), Qihang Zhang(Capital Medical University)
Cited by 3
Related Papers
Mesenchymal stem cell therapy for ischemic stroke: A look into treatment mechanism and therapeutic potential
|Journal of Neurology|2020|132
RNA-binding protein PCBP2 modulates glioma growth by regulating FHL3
|Journal of Clinical Investigation|2013|107
Risk factors for and outcomes of postoperative complications in adult patients with moyamoya disease
|Journal of neurosurgery|2018|105
Expression of Concern: Circadian gene Clock contributes to cell proliferation and migration of glioma and is directly regulated by tumor‐suppressive miR‐124
|FEBS Letters|2013|90
RNF213 as the major susceptibility gene for Chinese patients with moyamoya disease and its clinical relevance
|Journal of neurosurgery|2016|88